Cerus
CERS
#7424
Rank
A$0.63 B
Marketcap
A$3.31
Share price
0.66%
Change (1 day)
11.20%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -A$11.51 Million

According to Cerus's latest financial reports the company's current earnings are A$0.19 Billion. In 2024 the company made an earning of -A$17.06 Million, an increase over its 2023 earnings that were of -A$41.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$11.51 Million-32.52%
2024 -A$17.06 Million-58.95%
2023 -A$41.54 Million-20.74%
2022 -A$52.41 Million-25.7%
2021 -A$70.53 Million-11.99%
2020 -A$80.14 Million-14%
2019 -A$93.19 Million21.73%
2018 -A$76.55 Million-0.65%
2017 -A$77.05 Million-10.96%
2016 -A$86.54 Million4.24%
2015 -A$83.02 Million50.99%
2014 -A$54.99 Million-10.08%
2013 -A$61.15 Million184.13%
2012 -A$21.53 Million-7.91%
2011 -A$23.37 Million
2009 -A$33.01 Million-24.69%
2008 -A$43.83 Million-25.2%
2007 -A$58.59 Million330.54%
2006 -A$13.61 Million1.49%
2005 -A$13.41 Million-61.02%
2004 -A$34.4 Million
2002 -A$85.09 Million10.02%
2001 -A$77.34 Million34.25%
2000 -A$57.61 Million61.02%
1999 -A$35.78 Million-18.81%
1998 -A$44.07 Million93.08%
1997 -A$22.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$4.69 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$20.98 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.34 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.63 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA